Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

505024 Ibotenic Acid - CAS 2552-55-8 - Calbiochem

Ibotenic Acid - CAS 2552-55-8 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

同义词: 2-amino-2-(3-hydroxyisoxazol-5-yl) acetic acid, α-Amino-(3-hydroxy-5-isoxazolyl)acet­ic acid, Glutamate Receptor Agonist, Ibotenic acid

505024
Purchase on Sigma-Aldrich

概述

Replacement Information

重要规格表

CAS #Empirical Formula
2552-55-8C₅H₆N₂O₄

Products

产品目录编号包装 数量 / 包装
5.05024.0001.1753 玻璃瓶 1 mg
Description
OverviewA highly potent agonist of NMDA and mGlu receptors. A frequently used brain-lesioning agent inducing excitotoxic lesions of neurons without damaging crossing fiber tracts.
Catalogue Number505024
Brand Family Calbiochem®
Synonyms2-amino-2-(3-hydroxyisoxazol-5-yl) acetic acid, α-Amino-(3-hydroxy-5-isoxazolyl)acet­ic acid, Glutamate Receptor Agonist, Ibotenic acid
References
ReferencesIzquierdo, A., et al. 2013. J. Neurosci. 33, 4105.
Rhodes, V., et al. 2013. J. Neurosci. 33, 3380.
Yu, X., et al. 2012. Pharmacol. Biochem. & Beh. 101, 479.
Albasser, M., et al. 2012. Beh. Neurosci. 126, 659.
Eijkenboom, M., et al. 2000. Neurosci. 101, 27.
Isacson, O., et al. 1984. Nature. 311, 458.
Product Information
CAS number2552-55-8
FormWhite solid
Hill FormulaC₅H₆N₂O₄
Chemical formulaC₅H₆N₂O₄
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
Biological Information
Purity≥99% by HPLC
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
Toxicity Regulatory Review
Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
Storage -20°C
Protect from Light Protect from light
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
产品目录编号 GTIN
5.05024.0001.1753 04055977263329

Documentation

Ibotenic Acid - CAS 2552-55-8 - Calbiochem MSDS

职位

物料安全数据表 (MSDS) 

Ibotenic Acid - CAS 2552-55-8 - Calbiochem 分析证书

标题批号
505024

参考

参考信息概述
Izquierdo, A., et al. 2013. J. Neurosci. 33, 4105.
Rhodes, V., et al. 2013. J. Neurosci. 33, 3380.
Yu, X., et al. 2012. Pharmacol. Biochem. & Beh. 101, 479.
Albasser, M., et al. 2012. Beh. Neurosci. 126, 659.
Eijkenboom, M., et al. 2000. Neurosci. 101, 27.
Isacson, O., et al. 1984. Nature. 311, 458.
数据表

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision17-July-2013 JSW
Synonyms2-amino-2-(3-hydroxyisoxazol-5-yl) acetic acid, α-Amino-(3-hydroxy-5-isoxazolyl)acet­ic acid, Glutamate Receptor Agonist, Ibotenic acid
DescriptionA highly potent agonist of NMDA and mGlu receptors. A frequently used brain-lesioning agent inducing excitotoxic lesions of neurons without damaging crossing fiber tracts.
FormWhite solid
CAS number2552-55-8
Chemical formulaC₅H₆N₂O₄
Structure formulaStructure formula
Purity≥99% by HPLC
SolubilityH₂O (10 mM)
Storage Protect from light
-20°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity Regulatory Review
ReferencesIzquierdo, A., et al. 2013. J. Neurosci. 33, 4105.
Rhodes, V., et al. 2013. J. Neurosci. 33, 3380.
Yu, X., et al. 2012. Pharmacol. Biochem. & Beh. 101, 479.
Albasser, M., et al. 2012. Beh. Neurosci. 126, 659.
Eijkenboom, M., et al. 2000. Neurosci. 101, 27.
Isacson, O., et al. 1984. Nature. 311, 458.